HAIRY CELL LEUKEMIA VARIANT
Clinical trials for HAIRY CELL LEUKEMIA VARIANT explained in plain language.
Never miss a new study
Get alerted when new HAIRY CELL LEUKEMIA VARIANT trials appear
Sign up with your email to follow new studies for HAIRY CELL LEUKEMIA VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare leukemia: drug targets MEK gene in BRAF-Negative patients
Disease control Recruiting nowThis study tests a drug called binimetinib for people with hairy cell leukemia that does not have the common BRAF gene mutation. The drug targets a different gene, MEK, which is often altered in these patients. The goal is to see if it can shrink or control the cancer in 40 adult…
Matched conditions: HAIRY CELL LEUKEMIA VARIANT
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells take on rare leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment for hairy cell leukemia (HCL) that has come back or not responded to standard care. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. Up to 27 adults will receive chemo…
Matched conditions: HAIRY CELL LEUKEMIA VARIANT
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC